Financial Life Science Executives to Gather for Finance-Related Boardroom Event Company Culture, Data Mining, and Pharmaceutical Pricing Strategies to be Discussed.
The Executive Leadership Support Forum (ELS Forum) will provide executive assistants in the Greater New York City Area the opportunity for professional development and a collaborative exchange of methodologies.
Q1 Productions will host their 3rd Annual Global Postmarket Surveillance Of Medical Devices Conference in Alexandria, VA. Over 14 distinguished presenters are to attend, including four representatives from the FDA. This conference is one of a kind in networking, workshops and presentations.
The Medical Device Business Development conference, hosted by Q1 Productions, will be held January 30-31, 2015 in Atlanta, GA, and will offer perspectives from all corners of the medical device industry.
Aligning Clinical Research Strategies with EU Medical Device Regulation, Providing Greater Data to Support Product Registration, Enhancing Clinical Budget.
Empowering a New Generation of Leaders through Evaluation of Effective Training Methodologies, Coaching to Expand Global Mindset and Maximizing the Impact of Leadership Development to Build a High-Performance Culture.
Maximizing Strategic Partnerships through Licensing and Merger & Acquisition Activity in the Pharmaceutical and Biotech Spaces by Exploring Creative Deal Structures, Overcoming Funding Restraints and Capitalizing on Key National and Global External Opportunities.
Enhancing eDiscovery Practices through Risk Mitigation, Implementing Strategies for Cost-Containment and Reducing Volume of Data for Preservation, Collection and Review.
Examining Cost-Effective and Strategic eDiscovery Procedures Specific to Financial Institutions through Exploring New Methods of Data Preservation and Records Management, Addressing the Latest Federal Regulations and Agency Investigations, and Progressive Opportunities when Transitioning to Cloud Computing.
Moving Toward a Unified Reimbursement Process across Europe through the Creation of Specific Pathways for New & Existing Medical Technologies, while Meeting Increasing Clinical Data Requirements and Maximizing Positive HTA Decisions.
Satisfied Users & 
Approved Press Releases
